Metagenomi, ArriVent Launch Bid for Nasdaq - BioSpace

Retrieved on: 2024-01-08 13:58:44

Tags for this article:

Click the tags to see associated articles and topics

Metagenomi, ArriVent Launch Bid for Nasdaq - BioSpace. View article details on hiswai:

Excerpt

In November 2020, the gene editing startup closed a $65 million series A funding round, which was backed by Bayer, the Humboldt Fund, HOF Capital, ...

Article found on: www.biospace.com

View Original Article